Sprinklr (CXM) Tops Q3 EPS by 2c, Beats on Revenue; Offers FY25 Guidance
Go back to Sprinklr (CXM) Tops Q3 EPS by 2c, Beats on Revenue; Offers FY25 Guidance| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 6.91 +0.21 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.70 | 52 Week High | $1.44 | |||
| Open | $6.81 | 52 Week Low | $0.06 | |||
| Day High | $6.96 | P/E | N/A | |||
| Day Low | $6.72 | EPS | $-1.24 | |||
| Volume | 1,795,732 | |||||
